Ali Dalloul

Summary

Affiliation: CHU de Nancy
Country: France

Publications

  1. doi CD5: a safeguard against autoimmunity and a shield for cancer cells
    Ali Dalloul
    Thérapie cellulaire, CHU de Nancy Brabois, Bâtiment Hématologie Transfusion, rue du Morvan, 54500 Vandoeuvre les Nancy, France
    Autoimmun Rev 8:349-53. 2009
  2. ncbi Interleukin-24: a molecule with potential anti-cancer activity and a cytokine in search of a function
    Ali Dalloul
    Laboratory of cell therapy and University of Nancy Medical school, Vandoeuvre les Nancy, France
    Endocr Metab Immune Disord Drug Targets 9:353-60. 2009

Detail Information

Publications2

  1. doi CD5: a safeguard against autoimmunity and a shield for cancer cells
    Ali Dalloul
    Thérapie cellulaire, CHU de Nancy Brabois, Bâtiment Hématologie Transfusion, rue du Morvan, 54500 Vandoeuvre les Nancy, France
    Autoimmun Rev 8:349-53. 2009
    ..An important issue is therefore to better understand the molecules produced by tolerogenic or immunogenic microenvironments that respectively turn on or downregulate CD5 expression, with potential therapeutic implications...
  2. ncbi Interleukin-24: a molecule with potential anti-cancer activity and a cytokine in search of a function
    Ali Dalloul
    Laboratory of cell therapy and University of Nancy Medical school, Vandoeuvre les Nancy, France
    Endocr Metab Immune Disord Drug Targets 9:353-60. 2009
    ....